| Ipca Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524494 |
NSE Symbol : IPCALAB |
P/E(TTM) : 38.79 |
|
ISIN Demat : INE571A01038 |
Div & Yield% : 0.35 |
EPS(TTM) : 44.78 |
|
Book Value(₹) : 314.51 |
Market Cap(₹Cr) : 44,064.62 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 7,336.75 | 6,677.92 | 6,166.46 | 5,814.62 | 5,438.30 |
| Other Income | 94.64 | 71.29 | 111.29 | 111.19 | 52.92 |
| Stock Adjustments | 60.06 | -128.43 | 55.19 | -104.09 | 126.00 |
| Total Income | 7,491.45 | 6,620.78 | 6,332.94 | 5,821.72 | 5,617.22 |
| EXPENDITURE : | |||||
| Raw Materials | 1,916.84 | 1,764.88 | 2,033.57 | 1,964.94 | 1,911.88 |
| Power and Fuel Cost | 250.97 | 235.60 | 253.33 | 277.21 | 237.44 |
| Other Manufacturing Expenses | 385.83 | 367.61 | 356.81 | 311.74 | 279.03 |
| Selling and Administration Expenses | 1,077.02 | 953.42 | 846.95 | 812.67 | 612.89 |
| Miscellaneous Expenses | 358.43 | 503.13 | 314.87 | 236.31 | 179.67 |
| Employee Benefit Expenses | 1,655.90 | 1,479.34 | 1,336.19 | 1,193.39 | 1,102.14 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,846.46 | 1,316.80 | 1,191.22 | 1,025.46 | 1,294.17 |
| Interest | 45.46 | 65.06 | 122.58 | 46.34 | 10.41 |
| Gross Profit | 1,801.00 | 1,251.74 | 1,068.64 | 979.12 | 1,283.76 |
| Depreciation | 268.87 | 251.97 | 246.48 | 228.63 | 209.65 |
| Profit Before Tax | 1,532.13 | 999.77 | 822.16 | 750.49 | 1,074.11 |
| Current Tax | 402.12 | 340.90 | 288.01 | 223.95 | 197.28 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.51 | 8.11 | 3.74 | 20.84 | 16.46 |
| Reported Net Profit | 1,132.52 | 650.76 | 530.41 | 505.70 | 860.37 |
| Extraordinary Items | -3.46 | -169.55 | -69.52 | 17.51 | 7.86 |
| Adjusted Net Profit | 1,135.98 | 820.31 | 599.93 | 488.19 | 852.51 |
| Adjustment below Net Profit | 3.35 | -4.92 | -1.39 | -2.05 | 1.15 |
| Profit/Loss Balance carried down | 5,501.16 | 4,956.80 | 4,478.52 | 4,076.35 | 3,316.31 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 50.74 | 101.48 | 50.74 | 101.48 | 101.48 |
| P & L Balance carried down | 6,586.29 | 5,501.16 | 4,956.80 | 4,478.52 | 4,076.35 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 600.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Dividend Per Share(Rs) | 6.00 | 4.00 | 4.00 | 4.00 | 4.00 |
| Earnings Per Share-Unit Curr | 44.64 | 25.65 | 20.91 | 19.93 | 33.91 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 314.52 | 271.64 | 250.24 | 231.66 | 215.84 |
| Book Value(Adj)-Unit Curr | 314.52 | 271.64 | 250.24 | 231.66 | 215.84 |
